Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
申请人:SAVIRA PHARMACEUTICALS GMBH
公开号:US20140038990A1
公开(公告)日:2014-02-06
The present invention relates to a compound having the general formula (Di), (Dii), or (Diii), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,
which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
本发明涉及具有一般式(Di)、(Dii)或(Diii)的化合物,可选地为药学上可接受的盐、溶剂合物、多型体、共药、共晶、前药、互变异构体、消旋体、对映体或二对映体或其混合物,这些化合物在治疗、改善或预防病毒性疾病方面是有用的。此外,还披露了特定的联合疗法。